About Us

Advancing Vision Designed for Every Eye. Helping shape the future of vision care with solutions that support people through every stage of life.†3-8 At CooperVision, we're committed to advancing vision*1 through solutions designed for every eye and every stage of life.2,3 By combining innovation, expertise, and a deep understanding of people's evolving vision needs, we're helping more people around the world enjoy clear,†3-8 comfortable3,9,10 vision today while creating possibilities for tomorrow. From our groundbreaking introduction of contact lenses proven to slow the progression of myopia in children◊¶6 age 8-12 at the initiation of treatment; to our DigitalBoost™ technology, developed to address the needs of contact lens wearers who lead digital lifestyles; to our creation of the world’s first full family of 1-day silicone hydrogel contact lenses, CooperVision is advancing the range of what contact lenses can do—and bringing ocular advantages to contact lens wearers. * Combination of 2022 market research based on global volume data and internal estimates † VA (LogMAR) > 6/6 (20/20) at all visits from dispensing to 6-year visit. ‡ Based on Rx option combinations (sphere, cylinder, axis and add) manufactured, across all soft lenses in sphere, toric and multifocal (including made to order), in silicone hydrogel and hydrogel from 4 main manufacturers. Includes 1 Day, 2 weekly, and monthly disposable contact lenses. Cosmetic and photochromatic contact lenses not included. Multiple base curve variants not included. § Combination of 2013-2018 market research based on global revenue sales and internal estimates. ◊ Compared to a single vision 1 Day lens over a 3 year period. ¶ Product not available in all markets. 1. CVI data on file, 2023. 2. CVI data on file, 2021. Rx coverage database n=101,973 aged 14 to 70 years. 3. CVI data on file, 2026. 4. CVI data on file, 2024. 5. CVI data on file 2020. Prospective, double-masked, bilateral, one-week dispensing study with MyDay® multifocal; n=102 habitual MFCL wearers. 6. Chamberlain P, et al. A 3-year Randomized Clinical Trial of MiSight Lenses for Myopia Control. OVS 2019;96:556-567. 7. Chamberlain P, et al. Long-term Effect of Dual-focus Contact Lenses on Myopia Progression in Children: A 6-year Multicenter Clinical Trial. OVS 2022 Mar 1;99(3):204-212. 8. CVI data on file, 2018. clariti 1 day satisfaction survey, n=1718. CVI data on file, 2018. 1-week bilateral DW study with c1d toric, n=39. CVI data on file, 2019. Woods J et al. Visual performance with DD SiH CN progressive design MFCL. 9. CVI data on file, 2018.Observational satisfaction survey in France, n=1718. 10. Sulley A et al, Wearer experience and subjective responses with dual focus compared to spherical, single vision soft contact lenses in children during a 3-year clinical trial. AAO 2019 Poster Presentation.

Our HG Partnership

Show Offers